Pulmonx Q3 2024 GAAP EPS $(0.36) Beats $(0.45) Estimate, Sales $20.387M Beat $20.288M Estimate

pulmonx -4.54%

pulmonx

LUNG

7.36

-4.54%

Pulmonx (NASDAQ: LUNG) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.45) by 20 percent. The company reported quarterly sales of $20.387 million which beat the analyst consensus estimate of $20.288 million by 0.49 percent. This is a 15.39 percent increase over sales of $17.668 million the same period last year.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via